Valuation Result
Final Brand Value
Novonesis — Food Processing & Packaging
Valuation date: 10/30/2026
Total Brand Value
€667.9M
This result turns the selected legal, brand, benchmark and discount-rate assumptions into one reviewable brand value estimate.
Brand Strength
73/100
Royalty Rate
1.1%
Discount Rate
8.5%
Benchmark recommendation not unlocked for this result
Sensitivity snapshot
Quick decision check for discount rate, royalty rate and long-term growth.
Variable
Lower input
Current
Higher input
WACC (Discount Rate)
8.5%
-1.0%
€787.3M
8.5%
€667.9M
+1.0%
€580.5M
Royalty Rate
1.1%
-0.5%
€362.9M
1.1%
€667.9M
+0.5%
€972.9M
Terminal Growth
2.0%
-0.5%
€630.2M
2.0%
€667.9M
+0.5%
€712.0M
Brand Strength changes can also be explored to show their potential effect on brand value. Contact info@brandvaluator.se if you want to explore this for strategy, planning and budgeting.
Revenue Base
€4.2B
Legal Protection
75/100
Long-term Growth
2.0%
Recommendation basis
Brand-strength range • Pro
This reference case derives its royalty rate by applying the brand-strength score to a documented industry royalty ceiling.
This valuation uses benchmark support informed by external market references and curated internal calibration.
Use this section to confirm whether the result reflects unlocked benchmark guidance or a non-benchmark method.
Forecast profile
5 years explicit forecast
High growth: 6.0%
Base growth: 4.0%
Long-term growth: 2.0%
Value build
Value for planning period: €170.7M
Terminal value: €497.3M
How the valuation is built
Valuation Build
| Year | Revenue | Royalty | After Tax | PV |
|---|---|---|---|---|
| Y1 | €4,407,056,000 | €48,257,263 | €37,640,665 | €36,136,195 |
| Y2 | €4,671,479,360 | €51,152,699 | €39,899,105 | €35,303,564 |
| Y3 | €4,951,768,122 | €54,221,861 | €42,293,052 | €34,490,118 |
| Y4 | €5,149,838,846 | €56,390,735 | €43,984,774 | €33,059,652 |
| Y5 | €5,355,832,400 | €58,646,365 | €45,744,165 | €31,688,514 |
| Explicit PV (Y1–Y5) | €170,678,043 | |||
| Terminal Value (undiscounted) | €717,831,505 | |||
| Terminal PV (discounted) | €497,265,917 | |||
| Total Brand Value | €667,943,960 |
Supporting context
This section explains the evidence and judgment used to support the recommendation and the legal, brand and financial assumptions used in the valuation.
Reference case
Novonesis
Prepared reference case
Indicative value of the Novonesis name in enzymes, cultures and microbial solutions. Strains, patents, production and enterprise value are excluded.
The name dates only from 2024, so most accumulated goodwill sits in the retired Novozymes and Chr. Hansen names; this lowers mental availability and goodwill evidence. 2026 organic growth guidance is 5-7%. The 1.50% name-only ceiling and 1.095% selected royalty are analyst assumptions, not an observed licence. Opening hypothetical rent of EUR 45.5m is about 5.6% of EUR 816.7m FY2025 EBIT. Legal and behavioural inputs are outside-in estimates, not a trademark opinion or customer survey.
Informed by numerous sources including company reporting, investor materials, analyst research, market data and selected benchmark references where relevant.
Key inputs
Reported = directly sourced • Estimated = selected judgment • Inferred = derived from broader evidence • Assumed = inclusion choice
Revenue base
EUR 4.158bn FY2025 net salesreported
Planning growth
6.00% for 3 years, then 4.00%estimated
Long-term growth
2.00%estimated
Royalty rate selected
1.09%estimated
Discount rate
8.50%estimated
Brand Strength
73/100 (B)estimated
Legal analysis
75/100estimated
Company disclosures
These links lead to company-issued materials. BrandValuator cross-checks indicative estimates against multiple sources; the final assumptions and judgments are our own. Each input is labeled by evidence status above.
Legal Protection
trademark Status82
scope Of Rights78
risk Profile70
litigation74
contractual Rights76
goodwill Evidence66
regulatory Compliance78
Brand Strength
marketing Investment60
quality86
availability78
distinctive Brand Codes64
mental Availability62
consideration78
trust80
choice Share78
penetration72
price Elasticity66
revenue Premium72
margin Premium76
stability74